A study published in Molecular Therapy Advances reports that adenine base editing corrected a disease-related mutation and slowed motor neuron disease in a mouse model. The research was led by Professor Haruhisa Inoue of Kyoto University's Center for iPS Cell Research and Application and Professor Yuishin Izumi of Tokushima University.
The team demonstrated that the editing technique could repair the specific genetic error in living mice. After treatment, the animals showed a slower course of disease compared with untreated controls, suggesting that the mutation correction had a direct therapeutic effect.
The findings point to adenine base editing as a possible strategy for genetic forms of motor neuron disease. The authors caution that further studies will be needed before the approach can be considered for clinical use.